Canada markets closed

PreveCeutical Medical Inc (18H.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.01500.0000 (0.00%)
At close: 02:06PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
0
Gross Profit
-
-
-
0
Operating Expenses
Research Development
185.37
153.422
171.845
315.141
Selling General and Administrative
592.131
833.714
657.987
1,726
Total Operating Expenses
838.994
1,059
897.851
2,163
Operating Income or Loss
-838.994
-1,059
-897.851
-2,163
Interest Expense
-53.774
237.274
466.896
640.042
Total Other Income/Expenses Net
267.703
-185.276
-382.301
-1,004
Income Before Tax
-517.517
-1,481
-1,747
-3,807
Income Tax Expense
-
0
-20.477
-6.15
Income from Continuing Operations
-517.517
-1,481
-1,727
-3,801
Net Income
-517.517
-1,481
-1,727
-3,801
Net Income available to common shareholders
-517.517
-1,481
-1,727
-3,801
Basic EPS
-0.00
-0.00
-0.00
-0.01
Diluted EPS
-0.00
-0.00
-0.00
-0.01
Basic Average Shares
517,609
521,790
507,953
455,869
Diluted Average Shares
517,609
521,790
507,953
455,869